secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001493152-26-022024
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics issues warrant for 17.4M shares at $0.23 in private placement
--------------------------------------------------------------------------------

- Warrant to purchase up to 17,391,304 shares of common stock at $0.23 per share issued to accredited investor.
- Warrant first exercisable on September 8, 2026; vesting tied to future registered issuances of up to $4.0M.
- Registered issuances may occur before July 8, 2026 but neither party is obligated to complete them.
- Issuance exempt under Section 4(a)(2) and Rule 506(b) based on investor's accredited status.
- Shares issuable upon exercise are restricted; no registration statement filed for resale.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226022024/0001493152-26-022024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226022024/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-022024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer